Genentech Will Alert Physicians To Raptiva Anemia Warning
This article was originally published in The Pink Sheet Daily
Executive Summary
"Dear Healthcare Provider" letter will address a hemolytic anemia warning stemming from postmarketing surveillance of the plaque psoriasis therapy. A precaution on severe arthritis events also has been added.